Connor Griffin
Researcher
Also affiliated: University of South Carolina (2023–2024); Baylor University Medical Center (2017–2023); Baylor Medical Center at Garland (2022); Winthrop Rockefeller Foundation (2024)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Connor Griffin's research focuses on the epidemiology and mortality associated with liver diseases and hepatocellular carcinoma in the United States. His work has investigated trends in cirrhosis-related mortality among Medicare-eligible populations and explored extrahepatic causes of death in individuals with cirrhosis compared to other chronic conditions. Griffin also examines mortality patterns related to hepatocellular carcinoma over two decades.
His publications include research on the diagnosis and management of nonalcoholic fatty liver disease, as well as updates on assessing estimated glomerular filtration rates in patients with cirrhosis. Griffin has also contributed to a publication on virtual reality in the neurosciences and research on the induction of tumor cell dormancy in lung cancer. He collaborates with researchers across the University of Arkansas system.
Metrics
- h-index: 7
- Publications: 17
- Citations: 187
Selected Publications
-
CB-839 induces reversible dormancy in lung tumor-cells (2024)
-
Virtual Reality in the Neurosciences: Current Practice and Future Directions (2022)
Collaboration Network
Top Collaborators
- Virtual Reality in the Neurosciences: Current Practice and Future Directions
- Virtual Reality in the Neurosciences: Current Practice and Future Directions
- Virtual Reality in the Neurosciences: Current Practice and Future Directions
- Virtual Reality in the Neurosciences: Current Practice and Future Directions
- Virtual Reality in the Neurosciences: Current Practice and Future Directions
- Virtual Reality in the Neurosciences: Current Practice and Future Directions
- Virtual Reality in the Neurosciences: Current Practice and Future Directions
- CB-839 induces reversible dormancy in lung tumor-cells
- CB-839 induces reversible dormancy in lung tumor-cells
- CB-839 induces reversible dormancy in lung tumor-cells
- CB-839 induces reversible dormancy in lung tumor-cells
- CB-839 induces reversible dormancy in lung tumor-cells
- CB-839 induces reversible dormancy in lung tumor-cells
- CB-839 induces reversible dormancy in lung tumor-cells
- CB-839 induces reversible dormancy in lung tumor-cells
Similar Researchers
Based on overlapping research topics